Phase 1 Chronic Heart Failure Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
Chronic Heart Failure
Melana Yuzefpolskaya, MD40 enrolled1 locationNCT07490054
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
Chronic Heart FailureCoronary Artery Bypass Grafting (CABG)Chronic Ischemic Cardiomyopathy
Tasly Pharmaceutical Group Co., Ltd51 enrolled4 locationsNCT07265349
Completed
Phase 1
Study to find out if the drug “Vessel Dilator” is absorbed from an injection under the skin and, whether it improves heart function in people diagnosed with chronic heart failure and a moderate degree of kidney function loss.
Renal ImpairmentChronic Heart Failure
Madeleine Pharmaceuticals Pty Ltd8 enrolled1 locationACTRN12611000806965